Company Overview of MithraGen, Inc.
MithraGen, Inc. develops immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. It offers RetroVax, a product platform technology, which turns antigen containing class I and II epitopes into an immunostimulant. The company also provides RetroVax therapeutic vaccines. MithraGen, Inc. was formerly known as MithraTech, Inc. The company is based in Houston, Texas.
8030 El Rio
Houston, TX 77054
Key Executives for MithraGen, Inc.
Similar Private Companies By Industry
|Blu Caribe, Inc.||United States|
|Adnexus Therapeutics Inc.||United States|
|LifeCell Corporation||United States|
|EnviroGro Solutions, Inc.||United States|
|Vitreoretinal Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- Puerto Rico | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact MithraGen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.